These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25951434)

  • 1. Search for factors affecting antibacterial activity and toxicity of 1,2,4-triazole-ciprofloxacin hybrids.
    Plech T; Kaproń B; Paneth A; Kosikowska U; Malm A; Strzelczyk A; Stączek P; Świątek Ł; Rajtar B; Polz-Dacewicz M
    Eur J Med Chem; 2015 Jun; 97():94-103. PubMed ID: 25951434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the primary molecular target of 1,2,4-triazole-ciprofloxacin hybrids.
    Plech T; Kaproń B; Paneth A; Kosikowska U; Malm A; Strzelczyk A; Stączek P; Świątek Ł; Rajtar B; Polz-Dacewicz M
    Molecules; 2015 Apr; 20(4):6254-72. PubMed ID: 25859782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
    Plech T; Wujec M; Kosikowska U; Malm A; Rajtar B; Polz-Dacewicz M
    Eur J Med Chem; 2013 Feb; 60():128-34. PubMed ID: 23287058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents.
    Kant R; Singh V; Nath G; Awasthi SK; Agarwal A
    Eur J Med Chem; 2016 Nov; 124():218-228. PubMed ID: 27592391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis and Antibacterial Evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4H)-thione Hybrids.
    Gao Y; Na LX; Xu Z; Zhang S; Wang AP; Lü K; Guo HY; Liu ML
    Chem Biodivers; 2018 Oct; 15(10):e1800261. PubMed ID: 29987907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
    Ibrahim NM; Fahim SH; Hassan M; Farag AE; Georgey HH
    Eur J Med Chem; 2022 Jan; 228():114021. PubMed ID: 34871841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics.
    Pokrovskaya V; Belakhov V; Hainrichson M; Yaron S; Baasov T
    J Med Chem; 2009 Apr; 52(8):2243-54. PubMed ID: 19301822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, antimycobacterial and antibacterial activity of ciprofloxacin derivatives containing a N-substituted benzyl moiety.
    Wang S; Jia XD; Liu ML; Lu Y; Guo HY
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5971-5. PubMed ID: 22884110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological action of 1-aminomethyl derivatives of 3-R-4-phenyl-delta2-1,2,4-triazoline-5-thione.
    Pitucha M; Wujec M; Dobosz M; Kosikowska U; Malm A
    Acta Pol Pharm; 2005; 62(6):443-9. PubMed ID: 16583983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and molecular docking of new N-4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity.
    Mohammed HHH; Abdelhafez EMN; Abbas SH; Moustafa GAI; Hauk G; Berger JM; Mitarai S; Arai M; Abd El-Baky RM; Abuo-Rahma GEA
    Bioorg Chem; 2019 Jul; 88():102952. PubMed ID: 31039471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalently linked kanamycin - Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance.
    Shavit M; Pokrovskaya V; Belakhov V; Baasov T
    Bioorg Med Chem; 2017 Jun; 25(11):2917-2925. PubMed ID: 28343755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents.
    Wang Y; Damu GL; Lv JS; Geng RX; Yang DC; Zhou CH
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5363-6. PubMed ID: 22884108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution of terminal amide with 1H-1,2,3-triazole: Identification of unexpected class of potent antibacterial agents.
    Bi F; Ji S; Venter H; Liu J; Semple SJ; Ma S
    Bioorg Med Chem Lett; 2018 Mar; 28(5):884-891. PubMed ID: 29433923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antiproliferative and antimicrobial activity of new Mannich bases bearing 1,2,4-triazole moiety.
    Popiołek Ł; Rzymowska J; Kosikowska U; Hordyjewska A; Wujec M; Malm A
    J Enzyme Inhib Med Chem; 2014 Dec; 29(6):786-95. PubMed ID: 24506202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel triazole/isoxazole functionalized 7-(trifluoromethyl)pyrido[2,3-d]pyrimidine derivatives as promising anticancer and antibacterial agents.
    Naresh Kumar R; Jitender Dev G; Ravikumar N; Krishna Swaroop D; Debanjan B; Bharath G; Narsaiah B; Nishant Jain S; Gangagni Rao A
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2927-2930. PubMed ID: 27130357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin derivatives and their antibacterial activities.
    Zhang GF; Liu X; Zhang S; Pan B; Liu ML
    Eur J Med Chem; 2018 Feb; 146():599-612. PubMed ID: 29407984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of β-octaarginine.
    Purkayastha N; Capone S; Beck AK; Seebach D; Leeds J; Thompson K; Moser HE
    Chem Biodivers; 2015 Feb; 12(2):179-93. PubMed ID: 25676502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
    Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
    Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
    Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.
    Hofny HA; Mohamed MFA; Gomaa HAM; Abdel-Aziz SA; Youssif BGM; El-Koussi NA; Aboraia AS
    Bioorg Chem; 2021 Jul; 112():104920. PubMed ID: 33910078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.